Patent · US Expired

Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications

US6607501B2 · kind B2 · utility

37Cited by
12References
32Claims
0Family size

Assignees

Inventor

Key dates

Filing dateMay 14, 2001
Grant dateAug 19, 2003
Priority date
Expiry dateJul 20, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2202/0415
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The present invention is directed to a method of treating cells, tissues or organs using in vivo plasma separation by implanting a plasma separation filter device within a blood vessel of a patient, or allogenic, or xenogenic donor, continuously separating blood plasma from whole blood in vivo, directing the plasma from the plasma separation filter device to a bioreactor, and exposing the plasma to cells, tissue or an organ within the bioreactor utilizing immune separation membranes where necessary.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.